Aggressive Burkitt-like lymphoma of colon in a patient with prior celiac disease [0.03%]
克罗恩病患者的结肠伯基特样淋巴瘤の病例
M Ahluwalia,V Gotlieb,V Damerla et al.
M Ahluwalia et al.
Background: Celiac disease (CD) and immunosuppression are the two risk factors for gastrointestinal, as well as non-gastrointestinal, non-Hodgkin's lymphomas (NHL). Recent large retrospective studies confirm that celiac d...
Case Reports
The Yale journal of biology and medicine. 2006 Dec;79(3-4):173-5. DOI: 2006
Efficacy of low dose clofarabine in refractory precursor T- acute lymphoblastic leukemia [0.03%]
克罗拉滨低剂量治疗难治前体T急性淋巴细胞白血病的疗效评估
Jaehyuk Choi,Francine Foss
Jaehyuk Choi
Refractory T-lymphoblastic leukemia in adults has a poor prognosis in patients who relapse after allogeneic stem cell transplantation, and relatively few new agents have demonstrated activity. Clofarabine is a novel nucleoside analog that h...
Case Reports
The Yale journal of biology and medicine. 2006 Dec;79(3-4):169-72. DOI: 2006
Metastatic cervical carcinoma to the thyroid gland: a case report and review of the literature [0.03%]
颈段食道癌转移到甲状腺的病例报告及文献回顾
Elena Karapanagiotou,Muhammad Wasif Saif,Dimitra Rondoyianni et al.
Elena Karapanagiotou et al.
Although metastases within the thyroid gland are rare, they are not as infrequent as generally believed. Asymptomatic breast, lung, and renal cell carcinomas may metastasize to the thyroid. When they become symptomatic, diagnosis relies upo...
Case Reports
The Yale journal of biology and medicine. 2006 Dec;79(3-4):165-8. DOI: 2006
MyD88 predicts chemoresistance to paclitaxel in epithelial ovarian cancer [0.03%]
MYD88预测上皮性卵巢癌患者对紫杉醇的耐药性
Dan-Arin Silasi,Ayesha B Alvero,Jessica Illuzzi et al.
Dan-Arin Silasi et al.
Introduction: Early identification of chemoresistance in patients with ovarian cancer is of utmost importance in order to provide them with the most appropriate therapy. Recently, we described the expression of MyD88 in o...
Andrew J Sawyer,Joseph M Piepmeier,W Mark Saltzman
Andrew J Sawyer
Despite advances in diagnostic imaging and drug discovery, primary malignant brain tumors remain fatal. Median survival for patients with the most severe forms is rarely past eight months. The severity of the disease and the lack of substan...
Carlos E Stahlhut Espinosa,Frank J Slack
Carlos E Stahlhut Espinosa
Cancer is a complex and dynamic disease, involving a variety of changes in gene expression and structure. Traditionally, the study of cancer has focused on protein-coding genes, considering these as the principal effectors and regulators of...
Seth Rakoff-Nahoum
Seth Rakoff-Nahoum
Central to the development of cancer are genetic changes that endow these "cancer cells" with many of the hallmarks of cancer, such as self-sufficient growth and resistance to anti-growth and pro-death signals. However, while the genetic ch...
Viruses and human cancer [0.03%]
病毒与人类癌症
John B Liao
John B Liao
Multiple endocrine neoplasia type 1 (MEN1) as a cancer predisposition syndrome: clues into the mechanisms of MEN1-related carcinogenesis [0.03%]
多发性内分泌肿瘤1型(MEN1)作为一种癌前综合征：揭秘MEN1相关癌症发生的机制
Valeria Busygina,Allen E Bale
Valeria Busygina
Laura G Pedraza-Fariña
Laura G Pedraza-Fariña
Cancer is a disease of extreme heterogeneity. Microarray analysis has identified thousands of genes that are transcriptionally up- or down-regulated in tumor samples; molecularly characterized lesions that play a causative role in tumorigen...